Century Therapeutics Inc
NASDAQ:IPSC 4:00:00 PM EDT
| Market Cap (Intraday) | 127.92M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.59 |
| 50-Day MA | $1.74 |
| 200-Day MA | $3.06 |
Century Therapeutics Inc Stock, NASDAQ:IPSC
38th Street, 25 North, 11th Floor, Philadelphia, Pennsylvania 19104
United States of America
Phone: +1.267.817.5790
Number of Employees: 165
Description
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.